NR 661 Week 4 VISE Assessment: Familiarize Yourself (Summer 2019)

(NR 661 Week 4 VISE Assessment)

Know Presentation, DX and Management

Diagnoses List

1. Acute bronchitis-

• DESCRIPTION
• ETIOLOGY
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

2. Acute laryngopharyngitis

• DESCRIPTION
• ASSESSMENT FINDINGS
• PREVENTION
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

3. Acute maxillary sinusitis

• DESCRIPTION
• ETIOLOGY
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• PREVENTION
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• PREGNANCY/LACTATION CONSIDERATIONS
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

4. Allergic rhinitis

• DESCRIPTION
• ETIOLOGY
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• PREVENTION
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

5. Anxiety

• DESCRIPTION
• ETIOLOGY
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• PREGNANCY/LACTATION CONSIDERATIONS
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

6. Asthma

• DESCRIPTION
• ETIOLOGY
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• PREGNANCY/LACTATION CONSIDERATIONS
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

7. Back pain-

• DESCRIPTION
• ETIOLOGY
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• PREVENTION
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

8. BPH

• DESCRIPTION
• ETIOLOGY
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

9. Depressive disorder

• DESCRIPTION
• ETIOLOGY
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• PREVENTION
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

10. Diabetes Type II-

• DESCRIPTION
• ETIOLOGY
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• PREVENTION
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• PREGNANCY/LACTATION CONSIDERATIONS
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

11. Eczema

• DESCRIPTION
• ETIOLOGY
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• PREVENTION
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• CONSULTATION/REFERRAL
• FOLLOW UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

12. Fibromyalgia / myositis

• ASSESSMENT FINDINGS
• CONSULTATION/REFERRAL
• DESCRIPTION
• DIAGNOSTIC STUDIES
• DIFFERENTIAL DIAGNOSIS
• ETIOLOGY
• EXPECTED COURSE
• FOLLOW-UP
• INCIDENCE
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• POSSIBLE COMPLICATIONS
• PREVENTION
• RISK FACTORS

13. Hyperlipidemia

• DESCRIPTION
• ETIOLOGY
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• PREVENTION
• NONPHARMACOLOGICAL MANAGEMENT
• INDICATIONS FOR PHARMACOLOGICAL MANAGEMENT
• STATIN INTOLERANCE
• PHARMACOLOGIC MANAGEMENT
• SUMMARY OF LIPID LOWERING AGENTS
• PREGNANCY/LACTATION CONSIDERATIONS
• CONSIDERATIONS FOR SPECIAL POPULATIONS
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

14. Hypertension-

• ACC/AHA Classification of HTN
• ACC/AHA Target BP Goal
• ETIOLOGY
• ADULT
• PEDIATRIC
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• Pediatric Classification of HTN
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• PREVENTION
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• PRESCRIBING STRATEGIES
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

15. Hypothyroidism

• DESCRIPTION
• ETIOLOGY
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• PREVENTION
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• PREGNANCY/LACTATION CONSIDERATIONS
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

16. Nail fungus- Tinea Unguium- Tinea Corporis

• DESCRIPTION
• ETIOLOGY
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• PREVENTION
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• PREGNANCY/LACTATION CONSIDERATIONS
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• COMPLICATIONS

17. Obesity

• ETIOLOGY
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIAGNOSTIC STUDIES
• PREVENTION
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• SURGICAL MANAGEMENT
• PREGNANCY/LACTATION CONSIDERATIONS
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• OBESITY-RELATED COMPLICATIONS
• POSSIBLE COMPLICATIONS

18. Osteoarthritis

• DESCRIPTION
• ETIOLOGY
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• PREVENTION
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

19. Pain in hip, shoulder and knee

• DESCRIPTION
• ETIOLOGY
• PREVALENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• PREVENTION
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

20. Pain in knee

21. Pain in shoulder

22. Reflux esophagitis- GERD

• DESCRIPTION
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS

23. Tinea corporis

24. URI- COMMON COLD

• DESCRIPTION
• DIFFERENTIAL DIAGNOSIS
• ETIOLOGY
• EXPECTED COURSE
• FOLLOW-UP
• INCIDENCE
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• POSSIBLE COMPLICATIONS
• PREGNANCY/LACTATION CONSIDERATIONS
• PREVENTION
• RISK FACTORS

25. Urinary tract infection

• DESCRIPTION
• ETIOLOGY
• INCIDENCE
• RISK FACTORS
• ASSESSMENT FINDINGS
• DIFFERENTIAL DIAGNOSIS
• DIAGNOSTIC STUDIES
• PREVENTION
• NONPHARMACOLOGIC MANAGEMENT
• PHARMACOLOGIC MANAGEMENT
• PREGNANCY/LACTATION CONSIDERATIONS
• CONSULTATION/REFERRAL
• FOLLOW-UP
• EXPECTED COURSE
• POSSIBLE COMPLICATIONS